McKesson's board of directors elects new independent director
McKesson Corporation’s Board of Directors has elected Dominic Caruso as a new independent director, effective September 12, 2018. With the election of Dominic Caruso, McKesson’s Board of Directors increases from eight to nine members, eight of whom are independent.
“Dominic’s three decades of global financial and operational experience, leadership, and tenure in the healthcare industry make him an ideal addition to our Board of Directors,” McKesson Corporation chairman and CEO John Hammergren said. “His demonstrated commitment to rigorous financial stewardship complements McKesson’s dedication to strong financial management, disciplined growth and strategic capital allocation.”
“I'm delighted to be joining a company that I've long admired and look forward to adding my perspective and contributing to the company's future development and success,” Caruso said. “McKesson’s market leadership and deep customer and partner relationships position it for long-term growth in the healthcare industry. I look forward to helping chart the company’s path forward.”
Caruso, age 61, retired as executive vice president and the chief financial officer from Johnson & Johnson in August 2018, having served in the role since 2007. Dominic led the company’s financial and investor relations activities, as well as the procurement organization. Dominic joined Johnson & Johnson in October 1999 as chief financial officer for Centocor, Inc., upon the completion of the merger of Centocor and Johnson & Johnson. Prior to joining Centocor, he had varied industry experiences with KPMG.
He is also actively involved in government relations activities globally, including having served as the co-chair of the U.S. Chamber of Commerce Global Initiative on Health and the Economy. He currently serves on the Board of Trustees of The Children’s Hospital of Philadelphia and the Cystic Fibrosis Foundation.
McKesson’s Board has appointed Caruso to its Audit Committee and its Finance Committee.
“Dominic’s three decades of global financial and operational experience, leadership, and tenure in the healthcare industry make him an ideal addition to our Board of Directors,” McKesson Corporation chairman and CEO John Hammergren said. “His demonstrated commitment to rigorous financial stewardship complements McKesson’s dedication to strong financial management, disciplined growth and strategic capital allocation.”
“I'm delighted to be joining a company that I've long admired and look forward to adding my perspective and contributing to the company's future development and success,” Caruso said. “McKesson’s market leadership and deep customer and partner relationships position it for long-term growth in the healthcare industry. I look forward to helping chart the company’s path forward.”
Caruso, age 61, retired as executive vice president and the chief financial officer from Johnson & Johnson in August 2018, having served in the role since 2007. Dominic led the company’s financial and investor relations activities, as well as the procurement organization. Dominic joined Johnson & Johnson in October 1999 as chief financial officer for Centocor, Inc., upon the completion of the merger of Centocor and Johnson & Johnson. Prior to joining Centocor, he had varied industry experiences with KPMG.
He is also actively involved in government relations activities globally, including having served as the co-chair of the U.S. Chamber of Commerce Global Initiative on Health and the Economy. He currently serves on the Board of Trustees of The Children’s Hospital of Philadelphia and the Cystic Fibrosis Foundation.
McKesson’s Board has appointed Caruso to its Audit Committee and its Finance Committee.